OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neuroimmunology is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation	86
A systematic review of cases of CNS demyelination following COVID-19 vaccination	76
A case of longitudinally extensive transverse myelitis following vaccination against Covid-19	71
The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception	66
Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients	62
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study	61
The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases	58
Inflammation in Huntington's disease: A few new twists on an old tale	50
Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms	50
Stress and cancer. Part I: Mechanisms mediating the effect of stressors on cancer	48
The neutrophil-to-lymphocyte ratio in Alzheimer's disease: Current understanding and potential applications	46
Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature	42
Involvement of NFƙB and MAPK signaling pathways in the preventive effects of Ganoderma lucidum on the inflammation of BV-2 microglial cells induced by LPS	40
Stellate ganglion block reduces symptoms of Long COVID: A case series	40
Fasudil inhibits the activation of microglia and astrocytes of transgenic Alzheimer's disease mice via the downregulation of TLR4/Myd88/NF-κB pathway	36
New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure	34
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?	34
Toll-like receptors in Alzheimer's disease	34
Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature	33
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement	32
MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ9-tetrahydrocannabinol and cannabidiol in human macrophages	32
COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment	32
Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report	32
Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine	31
The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation	31

Multipotential and systemic effects of traumatic brain injury	31
A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease	30
Searching for autoimmune encephalitis: Beware of normal CSF	30
Modulation of the HMGB1/TLR4/NF-κB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis	28
The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease	28